4 days ago
ABVX
AnalystsYatin SunejaYatin Suneja's Stock Forecasts
AnalystsYatin Suneja
Analyst Ranking
Top 7%
#317 out of 5057 analysts
Average Return
+16.16%
Win Rate
59%75 out of 128
Risk vs Reward
Poor
Good
Yatin Suneja's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Reata Pharmaceuticals IncRETA | +376.00% | $36.21 | $172.36 | 2022-10-18 - 2023-09-25 | Strong Buy |
Phathom Pharmaceuticals IncPHAT | +353.99% | $2.76 | $12.53 | 2025-05-01 - 2025-10-13 | Strong Buy |
Zenas Biopharma IncZBIO | +223.26% | $8.21 | $26.54 | 2025-03-11 - 2025-10-13 | Strong Buy |
Zura Bio LtdZURA | +189.14% | $1.34 | $3.86 | 2025-03-25 - 2025-10-13 | Strong Buy |
Vigil Neuroscience IncVIGL | +175.68% | $2.92 | $8.05 | 2024-08-13 - 2025-08-05 | Strong Buy |
Yatin Suneja Analyst Color
Get additional color on Yatin Suneja's coverage of popular stocks
6 days ago
ACET
a month ago
ROIV
2 months ago
NBIX
2 months ago
ARGX
3 months ago
ABVX
a year ago
ARGX
a year ago
SYRE
2 years ago
CLDX
2 years ago
AXSM
2 years ago
LBPH
2 years ago
ARGX
2 years ago
ARGX
2 years ago
LRMR
2 years ago
RXDX
Yatin Suneja's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Abivax SaABVX | 3 | Strong Buy | $150.00 | +56.85% | Maintains | 4 days ago |
Adicet Bio IncACET | 3 | Strong Buy | $8.00 | +717.16% | Maintains | 6 days ago |
Moonlake ImmunotherapeuticsMLTX | 4 | Strong Buy | $20.00 | +87.62% | Maintains | 14 days ago |
Argenx SeARGX | 11 | Strong Buy | $1,070.00 | +33.82% | Reiterates | a month ago |
Roivant Sciences LtdROIV | 3 | Strong Buy | $21.00 | +29.55% | Maintains | a month ago |
Tourmaline Bio IncTRML | 3 | Hold | $48.00 | +0.19% | Downgrades | a month ago |
Dianthus Therapeutics IncDNTH | 2 | Strong Buy | $100.00 | +190.53% | Maintains | a month ago |
Forte Biosciences IncFBRX | 1 | Strong Buy | $75.00 | +408.47% | Initiates Coverage On | 2 months ago |
Cabaletta Bio IncCABA | 6 | Strong Buy | $15.00 | +502.41% | Maintains | 2 months ago |
Regeneron Pharmaceuticals IncREGN | 7 | Strong Buy | $815.00 | +46.13% | Maintains | 2 months ago |
Neurocrine Biosciences IncNBIX | 6 | Strong Buy | $175.00 | +27.41% | Maintains | 2 months ago |
Larimar Therapeutics IncLRMR | 6 | Strong Buy | $26.00 | +511.76% | Reiterates | 4 months ago |
Alumis IncALMS | 2 | Strong Buy | $18.00 | +290.46% | Reinstates | 4 months ago |
Anaptysbio IncANAB | 9 | Strong Buy | $90.00 | +177.26% | Maintains | 5 months ago |
Gh Research PLCGHRS | 1 | Strong Buy | $29.00 | +123.77% | Maintains | 5 months ago |
Phathom Pharmaceuticals IncPHAT | 3 | Strong Buy | $12.00 | -4.23% | Maintains | 5 months ago |
Zura Bio LtdZURA | 2 | Strong Buy | $15.00 | +288.60% | Reiterates | 7 months ago |
Inflarx NvIFRX | 3 | Strong Buy | $10.00 | +700.00% | Maintains | 7 months ago |
Zenas Biopharma IncZBIO | 2 | Strong Buy | $45.00 | +69.56% | Reiterates | 7 months ago |
Immunovant IncIMVT | 4 | Strong Buy | $44.00 | +153.60% | Maintains | 8 months ago |
Surrozen IncSRZN | 3 | Strong Buy | $45.00 | +225.62% | Upgrades | 9 months ago |
Spyre Therapeutics IncSYRE | 1 | Strong Buy | $65.00 | +243.64% | Maintains | a year ago |
Vigil Neuroscience IncVIGL | 2 | Strong Buy | $16.00 | N/A | Maintains | a year ago |
Praxis Precision Medicines IncPRAX | 2 | Strong Buy | $170.00 | N/A | Maintains | a year ago |
Q32 Bio IncQTTB | 1 | Strong Buy | $100.00 | N/A | Initiates Coverage On | a year ago |
Celldex Therapeutics IncCLDX | 4 | Strong Buy | $90.00 | N/A | Maintains | 2 years ago |
Axsome Therapeutics IncAXSM | 7 | Strong Buy | $125.00 | N/A | Maintains | 2 years ago |
Longboard Pharmaceuticals IncLBPH | 3 | Strong Buy | $32.00 | N/A | Maintains | 2 years ago |
Neumora Therapeutics IncNMRA | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 2 years ago |
Xenon Pharmaceuticals IncXENE | 2 | Strong Buy | $49.00 | N/A | Reiterates | 2 years ago |
Eyepoint Pharmaceuticals IncEYPT | 2 | Strong Buy | $55.00 | N/A | Maintains | 2 years ago |
Bioxcel Therapeutics IncBTAI | 2 | Strong Buy | $736.00 | N/A | Maintains | 2 years ago |
Biogen IncBIIB | 3 | Strong Buy | $350.00 | N/A | Upgrades | 2 years ago |
Prometheus Biosciences IncRXDX | 3 | Hold | $200.00 | N/A | Downgrades | 2 years ago |
Rapt Therapeutics IncRAPT | 2 | Strong Buy | $384.00 | N/A | Maintains | 3 years ago |
Acadia Pharmaceuticals IncACAD | 5 | Strong Buy | $22.00 | N/A | Upgrades | 3 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Hold | $116.50 | N/A | Downgrades | 3 years ago |
Sage Therapeutics IncSAGE | 3 | Strong Buy | $48.00 | N/A | Maintains | 3 years ago |
Reata Pharmaceuticals IncRETA | 1 | Strong Buy | $75.00 | N/A | Initiates Coverage On | 3 years ago |
Relmada Therapeutics IncRLMD | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Karuna Therapeutics IncKRTX | 1 | Strong Buy | $330.00 | N/A | Maintains | 3 years ago |
Bausch & Lomb CorpBLCO | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 3 years ago |
Climb Bio IncCLYM | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Seelos Therapeutics IncSEELQ | 1 | Strong Buy | $30,720.00 | N/A | Initiates Coverage On | 4 years ago |
Global Blood Therapeutics IncGBT | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 7 years ago |
Seagen IncSGEN | 1 | Strong Buy | $80.00 | N/A | Upgrades | 7 years ago |
Verona Pharma PLCVRNA | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.